Jamal et al. [87] built a brain tumor xenograft model initiated from CD133+ GSCs and discovered that γH2AX foci induction after irradiation in vivo was significantly reduced in CD133+ glioma cells, compared with CD133- cells in the same tumor. The gene discussed is PROM1; the disease is glioma.